Efficacy and Safety of DNN.31.19.026 for Ocular Hypertension or Primary Open-Angle Glaucoma
This study aims to evaluate the safety and efficacy of DNN.31.19.026 compared with Cosopt® for the treatment of ocular hypertension or primary open-angle glaucoma.
Participants of either sex, aged ≥18 years; [+2]
Participants diagnosed with primary open-angle glaucoma with no prior treatment... [+9]